5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19376782 | COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Oct 31, 2025 |
| 19267387 | COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | CHONG, KIMBERLY | 1636 | Non-Final OA | Jul 11, 2025 |
| 19097593 | ANTIBODY-OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF INDUCING DMD EXON 52 SKIPPING | LOCKARD, JON MCCLELLAND | 1647 | Final Rejection | Apr 01, 2025 |
| 19097573 | ANTIBODY-OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF INDUCING DMD EXON 50 SKIPPING | PUTTLITZ, KARL J | 1646 | Final Rejection | Apr 01, 2025 |
| 16649572 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING | GIBBS, TERRA C | 1635 | Final Rejection | Mar 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial